ÂÜÀòÂÒÂ×

Michael Lees is a seasoned professional in health economics and market access, currently serving as Partner and Chief Operating Officer at Putnam since July 2020. Previously, Michael held the position of Head of Value, Evidence & Portfolio Strategy at Takeda, and from August 2010 to September 2017, contributed significantly at Bristol-Myers Squibb as Group Director in Worldwide Health Economics and Outcomes Research for Oncology. Notable early roles include Global Market Access and HEOR Lead for Xarelto at Bayer HealthCare and Health Economics Lead positions at Oxford Outcomes and M-TAG. Michael's academic credentials include a Master of Commerce focused on Issues Management and Policy from the University of Sydney, complemented by a Bachelor of Agricultural Economics from the same institution.